[
  {
    "date": "2023-12-31",
    "symbol": "CNTB",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "currentfiscalyearenddate": "--12-31",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-40212",
    "entityregistrantname": "Connect Biopharma Holdings Limited",
    "entityincorporationstatecountrycode": "E9",
    "entityaddressaddressline1": "12265 El Camino Real",
    "entityaddressaddressline2": "Suite 350",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "entityaddresscountry": "US",
    "contactpersonnelname": "Dr. Zheng Wei",
    "cityareacode": "+1 (858)",
    "localphonenumber": "727-1040",
    "phonefaxnumberdescription": "+1 (858) 614-7007",
    "security12btitle": "American Depositary Shares, each representing one Ordinary Share, par value $0.000174 per Share",
    "tradingsymbol": "CNTB",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 55102954,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1835268,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2023,
    "auditorfirmid": 1424,
    "auditorname": "PricewaterhouseCoopers Zhong Tian LLP",
    "auditorlocation": "Beijing, the People’s Republic of China",
    "researchanddevelopmentexpense": 51913000,
    "administrativeexpense": 14515000,
    "impairmentloss": 4700000,
    "otherincome": 1580000,
    "othergainslosses": 2774000,
    "profitlossfromoperatingactivities": -62074000,
    "financeincome": 2714000,
    "financecosts": 23000,
    "financeincomecost": 2691000,
    "profitlossbeforetax": -59383000,
    "incometaxexpensecontinuingoperations": 120000,
    "profitloss": -59503000,
    "profitlossattributabletoownersofparent": -59503000,
    "basicearningslosspershare": -1.08,
    "dilutedearningslosspershare": -1.08,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -604000,
    "othercomprehensiveincomenetoftaxfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincome": 354000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": -250000,
    "comprehensiveincome": -59753000,
    "comprehensiveincomeattributabletoownersofparent": -59753000,
    "propertyplantandequipment": 4274000,
    "rightofuseassets": 453000,
    "intangibleassetsandgoodwill": 62000,
    "othernoncurrentassets": 132000,
    "noncurrentassets": 4921000,
    "currentprepaymentsandothercurrentassets": 2318000,
    "currentfinancialassetsatfairvaluethroughothercomprehensiveincome": 12646000,
    "cashandcashequivalents": 106007000,
    "currentassets": 120971000,
    "assets": 125892000,
    "noncurrentleaseliabilities": 180000,
    "noncurrentdeferredincomeotherthannoncurrentcontractliabilities": 405000,
    "noncurrentliabilities": 585000,
    "tradeandotherpayablestotradesuppliers": 7660000,
    "othercurrentpayablesandaccruals": 2999000,
    "currentcontractliabilities": 13320000,
    "currentleaseliabilities": 285000,
    "currentliabilities": 24264000,
    "liabilities": 24849000,
    "netassetsliabilities": 101043000,
    "issuedcapital": 10000,
    "sharepremium": 628707000,
    "treasuryshares": 180000,
    "reserveofsharebasedpayments": 19731000,
    "otherreserves": -7878000,
    "retainedearnings": -539347000,
    "equity": 101043000,
    "equityandliabilities": 125892000,
    "increasedecreaseinnumberofordinarysharesissuedvalue": 44000,
    "increasedecreasethroughexerciseofoptions": 2000,
    "increasedecreasethroughsharebasedpaymenttransactions": 3259000,
    "increasedecreasethroughtransactionswithowners": 46000,
    "cashflowsfromusedinoperations": -47930000,
    "cashflowsfromusedinoperatingactivities": -47930000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 294000,
    "purchaseofavailableforsalefinancialassets": 1573000,
    "purchaseoffinancialassetsatfairvaluethroughothercomprehensiveincome": 31028000,
    "proceedsfromotherlongtermassetsclassifiedasinvestingactivities": 2943000,
    "proceedsfromdisposalormaturityofavailableforsalefinancialassets": 1578000,
    "proceedsfrommaturitiesoffinancialassetsatfairvaluethroughcomprehensiveincome": 103613000,
    "paymentofinvestmentmanagementfee": 84000,
    "cashflowsfromusedininvestingactivities": 75155000,
    "proceedsfromissueofordinaryshares": 44000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 290000,
    "cashflowsfromusedinfinancingactivities": -246000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 26979000,
    "effectofexchangeratechangesoncashandcashequivalents": 18000,
    "disclosureofotherincomeexpensenetexplanatorytextblock": "Other (Losses)/Gains—net",
    "disclosureofothernoncurrentassetexplanatorytextblock": "Other Non-Current Assets",
    "disclosureofsharecapitalreservesexplanatorytextblock": "Reserves",
    "disclosureofotherpayablesandaccrualsexplanatorytextblock": "Other Payables and Accruals",
    "disclosureoffinancialinstrumentswithpreferredrightsexplanatorytextblock": "Financial Instruments with Preferred Rights",
    "disclosureofrestrictednetassetsandparentcompanycondensedfinancialinformationexplanatorytextblock": "Restricted net Assets and Parent Company only Condensed Financial Information",
    "descriptionofaccountingpolicyforbasisofpreparationexplanatorypolicytextblock": "2.1 Basis of preparationThe Group’s consolidated financial statements were prepared in accordance with International Financial Reporting Standards (“IFRS Accounting Standards”) issued by the International Accounting Standards Board (“IASB”). The Group",
    "disclosureofdetailedinformationaboutfunctionalcurrencytextblock": "The subsidiaries have the following functional currencies:",
    "disclosureofaggregatenetforeignexchangegainslossesrecognizedinprofitorlossexplanatorytabletextblock": "The aggregate net foreign exchange (losses)/gains recognized in profit or loss were:Year Ended December 31, (In thousands)202120222023Net foreign exchange (losses)/gains included in other (losses)/gains—net$(516)$1,469 $367",
    "disclosureofotherincomeexplanatorytabletextblock": "Year Ended December 31,(In thousands)202120222023Government grantsi$2,950 $929 $1,580",
    "disclosureofdetailedinformationaboutfinanceincomecostnettabletextblock": "Year Ended December 31, (In thousands)202120222023Finance incomeInterest from bank, term, and other deposits$97 $192 $684 Interest income from investments at fair value through other comprehensive income— 1,352 2,030 97 1,544 2,714 Finance costInterest for lease liabilities(7)(21)(23)(7)(21)(23)Finance income—net$90 $1,523 $2,691",
    "disclosureofquantitativeinformationaboutleaseliabilitiesexplanatorytabletextblock": "The following tables provide information regarding these leases.",
    "disclosureofscheduleofotherreceivablesandprepaymentstabletextblock": "As of December 31, (In thousands)20222023Prepayment for clinical trials and drug manufacturing services$2,710 $1,732 Prepaid expenses369 357 Deposits51 51 Others232 178 $3,362 $2,318",
    "scheduleoffinancialassetsatfairvaluethroughcomprehensiveincomeexplanatorytabletextblock": "Financial assets at FVOCI consist of investments in the following:",
    "summaryofchangesinfinancialinstrumentsofshorttermandlongterminvestmentstabletextblock": "The following amounts table presents changes in Level 1 and 2 instruments of short-term and long-term investments for debt investments at FVOCI:",
    "disclosureoffinancialassetsatfairvaluethroughprofitorlosstabletextblock": "The following table presents the changes in Level 3 instruments of short-term investments in wealth management products:",
    "disclosureofsummaryofcashandcashequivalentsexplanatorytabletextblock": "As of December 31, (In thousands)20222023Cash at bank- USD deposits$50,739 $10,767 - RMB deposits9,169 15,614 - Australian Dollar deposit734 1,309 Cash equivalentsi18,368 78,317  $79,010 $106,007",
    "disclosureofscheduleofotherpayablesandaccrualstabletextblock": "As of December 31, (In thousands)20222023Construction payables$201 $4 Payroll, welfare and bonus payables2,148 1,916 Accrued professional service fee816 645 Others336 434  $3,501 $2,999",
    "disclosureofsummaryoffinancialinstrumentswithpreferredrightsexplanatorytabletextblock": "The Group has completed a series of financings by issuing preferred shares with the following details:Date of subscriptionRoundNumber ofpreferred sharesSubscriptionconsideration(In thousands)March 3, 2016Series Pre-A3,109$5,000 January 3, 2017Series A8,47120,000 December 20, 2018Series B10,12855,000 August 21, 2020/December 1, 2020Series C21,350135,000 43,058$215,000",
    "disclosureofsupplementalcashflowinformationexplanatorytabletextblock": "Supplemental Cash Flow Information:Year Ended December 31,(In thousands)202120222023Interest received$97 $419 $3,204 Income taxes paid— 462 120",
    "disclosureofnoncashinvestingandfinancingactivitiesexplanatorytabletextblock": "(b) Non-cash investing and financing activitiesYear Ended December 31,(In thousands)Notes202120222023Construction payables$2,631 $201 $4 Fair value changes of financial instruments with preferred rights25103,983 — —  $106,614 $201 $4",
    "disclosureofcondensedfinancialinformationforparentcompanyexplanatorytabletextblock": "Condensed balance sheets",
    "entityincorporationdateofincorporation": "2015-11-23",
    "countryofincorporation": "Cayman Islands",
    "addressofregisteredofficeofentity": "P.O. Box 613, Harbour Centre, George Town, Grand Cayman KY1-1107, Cayman Islands.",
    "numberofsharesrepresentedbyonedepositaryshares": 1,
    "parvaluepershare": 0.000174,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Investment holding",
    "principalplaceofbusinessofsubsidiary": "Hong Kong",
    "proportionofownershipinterestinsubsidiary": 1,
    "accumulatedothercomprehensiveincome": -539300000,
    "cash": 440100000,
    "cashcashequivalentandshortterminvestments": 118700000,
    "operatingleasetermofcontract": "P2Y",
    "numberofsegments": 1,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P5Y",
    "descriptionofusefullifepropertyplantandequipment": "Shorter of lease term",
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 367000,
    "percentageofforeignexchangetransaction": 0.05,
    "increasedecreasethroughforeignexchangefinancialassets": 700000,
    "otherpayables": 1083000,
    "leaseliabilities": 301000,
    "financialliabilities": 9044000,
    "cashequivalents": 78317000,
    "financialassetsatfairvaluethroughothercomprehensiveincome": 1750000,
    "financialassets": 80067000,
    "valueaddedtaxpayables": 5600000,
    "contractliabilities": 100000000,
    "clinicaltrialsrelatedexpenses": 40616000,
    "employeebenefitsexpense": 15438000,
    "professionalfeesexpense": 7545000,
    "rawmaterialsandconsumablesused": 527000,
    "depreciationandamortisationexpense": 988000,
    "officeexpenses": 716000,
    "otherexpensebynature": 598000,
    "expensebynature": 66428000,
    "expensefromsharebasedpaymenttransactionswithemployees": 3259000,
    "wagesandsalaries": 10409000,
    "welfareexpenses": 1559000,
    "housingfunds": 211000,
    "governmentgrants": 1580000,
    "revenuefromgovernmentgrantsfromothersubsidies": 700000,
    "revenuefromgovernmentasanincentiveforresearchanddevelopment": 900000,
    "profitslossesondisposalofinvestmentsandchangesinvalueofinvestments": 2503000,
    "investmentincome": 5000,
    "miscellaneousothernonoperatingincomeexpense": -101000,
    "lossespartiallyrecoveredfromcyberinsurance": 200000,
    "interestincomeondeposits": 684000,
    "interestandinvestmentincomefrominvestmentsatfairvaluethroughothercomprehensiveincome": 2030000,
    "interestexpenseonleaseliabilities": 23000,
    "applicabletaxrate": 0.3,
    "corporateincometaxrate": 0.21,
    "averageeffectivetaxrate": 0.0884,
    "taxexpenseincomeatapplicabletaxrate": -14846000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 366800000,
    "unusedtaxcreditsforwhichnodeferredtaxassetrecognised": 5900000,
    "profitlossfromcontinuingoperationsbeforetax": -27321000,
    "profitlossfromoverseasentities": -32062000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 354000,
    "incometaxsuperdeductionofresearchanddevelopmentexpenses": 5945000,
    "taxlossesanddeductibletemporarydifferencesforwhichnodeferredincometaxassetsrecognized": 22827000,
    "taxeffectofforeigntaxrates": -2270000,
    "weightedaverageshares": 55067000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -73000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 83000,
    "disposalspropertyplantandequipment": 1000,
    "depreciationpropertyplantandequipment": 494000,
    "noncurrentvalueaddedtaxreceivables": 108000,
    "othernoncurrentassetsother": 24000,
    "additionstorightofuseassets": 305000,
    "depreciationrightofuseassets": 22000,
    "rightofuseassetsgovernmentrepurchase": -3108000,
    "rightofuseassetsexchangedifference": 37000,
    "rightofuseassetsrevaluedassetsatcost": 1193000,
    "rightofuseassetsaccumulateddepreciation": 740000,
    "interestexpense": 23000,
    "cashoutflowforleases": 300000,
    "currentprepaidclinicaltrialsanddrugmanufacturingservices": 1732000,
    "currentprepaidexpenses": 357000,
    "currentdeposits": 51000,
    "othercurrentreceivables": 178000,
    "noncurrentfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincome": 1686000,
    "currentfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincome": 38983000,
    "interestincomerecognizedinprofitandlossrelatedtodebtinvestments": 2030000,
    "lossesrecognizedinothercomprehensiveincomerelatedtodebtinvestments": 354000,
    "maturitiesofdebtinvestmentsatfairvaluethroughothercomprehensiveincome": 92900000,
    "financialassetsatfairvaluethroughprofitorloss": 78317000,
    "financialassetsliabilitiesatfairvaluethroughprofitorloss": 78300000,
    "financialassetsmeasuredatfairvaluethroughothercomprehensiveincome": 12646000,
    "purchasesoffinancialassetsatfairvaluethroughothercomprehensiveincome": 31028000,
    "settlementsfairvaluemeasurementassets": 103613000,
    "accruedinterestsoffinancialassetatfairvaluethroughothercomprehensiveincome": 327000,
    "discountaccretedoffinancialassetsatfairvaluethroughothercomprehensiveincome": 1703000,
    "gainslossesrecognisedinothercomprehensiveincomefairvaluemeasurementassets": 354000,
    "purchasesfairvaluemeasurementassets": 1573000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementassets": 5000,
    "balanceswithbanks": 10767000,
    "depositsinsweepaccountsannualizedyield": 0.042,
    "issuedcapitalordinaryshares": 76560000,
    "numberofsharesoutstanding": 57508545,
    "increasedecreaseinnumberofordinarysharesissued": 60207,
    "numberofsharesissued": 3109000,
    "numberoftreasuryshares": 2405591,
    "percentageofentityprofittooffsetpriorlosses": 0.1,
    "percentageofentitysreserveregisteredcapital": 0.5,
    "statutoryreserve": 14200000,
    "periodofgrantofsharebasedpaymentarrangement": "P10Y",
    "sharebasedpaymentawardvestingperiod": "P4Y",
    "sharebasedpaymentawardvestingrightspercentage": 0.25,
    "sharebasedpaymentequalmonthlyinstallments": "P36M",
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 6000000,
    "percentageofsharesequaltolesserofaggregatenumberofordinaryshares": 0.05,
    "increaseinpercentageofsharesequaltolesserofaggregatenumberofordinaryshares": 0.05,
    "sharebasedcompensationarrangementissuableupontheexerciseofincentiveshareoptions": 60000000,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 2324087,
    "ordinarysharesreserved": 5278658,
    "sharespurchasedatdiscountedprice": 0.73,
    "purchaseofemployeesshares": 60207,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P8Y2M12D",
    "currentretentionpayables": 14000,
    "numberofsharesissuedatconsolidation": 46232,
    "weightedaveragesharepriceshareoptionsgranted2019": 0.77,
    "weightedaveragesharepriceshareoptionsgrantedatconsolidation": 1.57,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.036,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.593,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 1437000,
    "numberofoutstandingshareoptions": 6547621,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 1500,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 878593,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 3019701,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 1.12,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.75,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 5.31,
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 1.12,
    "expectedearlyexercisemultiple": 2.2,
    "forfeiturerateshareoptionsgranted": 0.083,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 0.64,
    "forfeiturerateshareoptionsgrantedexecutives": 0.083,
    "currentconstructionpayables": 4000,
    "currentpayrollwelfareandbonuspayables": 1916000,
    "currentaccruedprofessionalservicefee": 645000,
    "othercurrentpayables": 434000,
    "preferredsharessubscriptionconsideration": 5000000,
    "conversionfrompreferredsharestoordinarysharesaftershareconsolidation": 24745572,
    "adjustmentsforinvestmentincomefrominvestmentsinwealthmanagementproducts": 5000,
    "adjustmentsforinterestincomefrominvestmentatfairvaluethroughothercomprehensiveincome": 2030000,
    "adjustmentsforamortisationexpense": 9000,
    "adjustmentsfordepreciationexpense": 707000,
    "adjustmentsfordepreciationofrightsofuseassets": 272000,
    "adjustmentsforsharebasedpayments": 3259000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -367000,
    "gainslossesondisposalsofnoncurrentassets": -100000,
    "adjustmentsfordecreaseincreaseinotheroperatingreceivables": 1044000,
    "adjustmentsfordecreaseincreaseinotherassets": 120000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": -475000,
    "adjustmentsforincreasedecreaseindeferredgovernmentgrants": -247000,
    "adjustmentsforincreasedecreaseincontractliabilities": 13320000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": -4277000,
    "interestreceived": 3204000,
    "incometaxespaidrefund": 120000,
    "constructionpayablesnoncashinvestingandfinancingactivities": 4000,
    "noncashinvestingandfinancingactivities": 4000,
    "liabilitiesarisingfromfinancingactivities": 465000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -290000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 301000,
    "increasedecreasethroughinterestexpenseliabilitiesarisingfromfinancingactivities": 23000,
    "keymanagementpersonnelcompensationshorttermemployeebenefitsaccruedbonuses": 600000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2262000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1410000,
    "keymanagementpersonnelcompensationotherlongtermbenefits": 57000,
    "keymanagementpersonnelcompensation": 3729000,
    "percentageofannualrequirenetaftertaxprofits": 0.1,
    "percentageofreservefundofregisteredcapital": 0.5,
    "interestinsubsidiary": 330947000,
    "othercurrentassets": 356000,
    "equityattributabletoownersofparent": 427840000
  },
  {
    "date": "2022-12-31",
    "symbol": "CNTB",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Connect Biopharma Holdings Limited",
    "entitycentralindexkey": 1835268,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entitywellknownseasonedissuer": "No",
    "icfrauditorattestationflag": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycommonstocksharesoutstanding": 55041247,
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "tradingsymbol": "CNTB",
    "security12btitle": "American Depositary Shares, each representing one Ordinary Share, par value $0.000174 per Share",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "E9",
    "entityfilenumber": "001-40212",
    "contactpersonnelname": "Dr. Zheng Wei",
    "entityaddressaddressline1": "12265 El Camino Real",
    "entityaddressaddressline2": "Suite 350",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresscountry": "US",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": "+1 (858)",
    "localphonenumber": "727-1045",
    "phonefaxnumberdescription": "+1 (858) 614-7007",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorname": "PricewaterhouseCoopers Zhong Tian LLP",
    "auditorlocation": "Beijing, the People’s Republic of China",
    "auditorfirmid": 1424,
    "researchanddevelopmentexpense": 652211000,
    "administrativeexpense": 139444000,
    "impairmentloss": 32805000,
    "otherincome": 6438000,
    "othergainslosses": 12433000,
    "profitlossfromoperatingactivities": -805589000,
    "financeincome": 10715000,
    "financecosts": 144000,
    "financeincomecost": 10571000,
    "profitlossbeforetax": -795018000,
    "incometaxexpensecontinuingoperations": 2037000,
    "profitloss": -797055000,
    "profitlossattributabletoownersofparent": -797055000,
    "basicearningslosspershare": -14.5,
    "dilutedearningslosspershare": -14.5,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -135188000,
    "othercomprehensiveincomenetoftaxfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincome": -2513000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslationotherthantranslationofforeignoperations": 250065000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": 112364000,
    "comprehensiveincome": -684691000,
    "comprehensiveincomeattributabletoownersofparent": -684691000,
    "propertyplantandequipment": 34659000,
    "rightofuseassets": 24337000,
    "intangibleassetsandgoodwill": 499000,
    "noncurrentfinancialassetsatfairvaluethroughothercomprehensiveincome": 65744000,
    "othernoncurrentassets": 1754000,
    "noncurrentassets": 126993000,
    "otherreceivablesandprepayments": 23413000,
    "currentfinancialassetsatfairvaluethroughothercomprehensiveincome": 511250000,
    "cashandcashequivalents": 550274000,
    "currentassets": 1084937000,
    "assets": 1211930000,
    "noncurrentleaseliabilities": 1704000,
    "noncurrentdeferredrevenue": 4539000,
    "noncurrentliabilities": 6243000,
    "tradeandotherpayablestotradesuppliers": 83138000,
    "otherpayablesandaccruals": 24385000,
    "currentleaseliabilities": 1294000,
    "currentliabilities": 108817000,
    "liabilities": 115060000,
    "netassetsliabilities": 1096870000,
    "issuedcapital": 66000,
    "sharepremium": 4094566000,
    "treasuryshares": 1164000,
    "sharebasedcompensationreserves": 107502000,
    "otherreserves": 71120000,
    "retainedearnings": -3175220000,
    "equity": 1096870000,
    "equityandliabilities": 1211930000,
    "unrealizedlossesfrominvestments": -2513000,
    "gainslossesonexchangedifferencesontranslationnetoftax": 114877000,
    "increasedecreaseinvalueofordinarysharesissued": 132000,
    "increasedecreasethroughsharebasedpaymenttransactions": 45598000,
    "contributionsbyanddistributionstoownersofparent": 132000,
    "cashflowsfromusedinoperations": -679665000,
    "cashflowsfromusedinoperatingactivities": -679665000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 29320000,
    "purchaseofavailableforsalefinancialassets": 41000000,
    "purchaseoffinancialassetsatfairvaluethroughothercomprehensiveincome": 737494000,
    "proceedsfromdisposalormaturityofavailableforsalefinancialassets": 41140000,
    "proceedsfrommaturitiesoffinancialassetsatfairvaluethroughcomprehensiveincome": 195364000,
    "cashflowsfromusedininvestingactivities": -571310000,
    "proceedsfromexerciseofoptions": 758000,
    "proceedsfromissueofordinaryshares": 132000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 1515000,
    "cashflowsfromusedinfinancingactivities": -625000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -1251600000,
    "effectofexchangeratechangesoncashandcashequivalents": 94994000,
    "entityincorporationdateofincorporation": "2015-11-23",
    "countryofincorporation": "Cayman Islands",
    "addressofregisteredofficeofentity": "P.O. Box 613, Harbour Centre, George Town, Grand Cayman KY1-1107, Cayman Islands.",
    "numberofsharesrepresentedbyonedepositaryshares": 1,
    "parvaluepershare": 0.000174,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Investment holding",
    "principalplaceofbusinessofsubsidiary": "Hong Kong",
    "proportionofownershipinterestinsubsidiary": 1,
    "accumulatedothercomprehensiveincome": 3175200000,
    "cash": 440100000,
    "closingforeignexchangerate": 6.9646,
    "cashcashequivalentandshortterminvestments": 1061500000,
    "depreciationmethodpropertyplantandequipment": "Depreciation is calculated using the straight-line method",
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P10Y",
    "operatingleasetermofcontract": "P2Y",
    "numberofsegments": 1,
    "preferredsharesconversionratio": 1,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P5Y",
    "descriptionofusefullifepropertyplantandequipment": "Shorter of lease term",
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 9629000,
    "percentageofforeignexchangetransaction": 0.05,
    "increasedecreaseinforeignexchangetransactions": 5700000,
    "otherpayables": 9426000,
    "leaseliabilities": 1570000,
    "financialliabilities": 94134000,
    "cashequivalents": 127926000,
    "financialassetsatfairvaluethroughothercomprehensiveincome": 283238000,
    "financialassets": 411164000,
    "clinicaltrialsrelatedexpenses": 551771000,
    "employeebenefitsexpense": 143819000,
    "professionalfeesexpense": 69312000,
    "rawmaterialsandconsumablesused": 7990000,
    "depreciationandamortisationexpense": 6940000,
    "officeexpenses": 5056000,
    "otherexpensebynature": 6767000,
    "expensebynature": 791655000,
    "expensefromsharebasedpaymenttransactionswithemployees": 45598000,
    "wagesandsalaries": 84356000,
    "welfareexpenses": 12191000,
    "housingfunds": 1674000,
    "governmentgrants": 6438000,
    "revenuefromgovernmentgrantsfromothersubsidies": 5900000,
    "profitslossesondisposalofinvestmentsandchangesinvalueofinvestments": 1711000,
    "investmentincome": 140000,
    "othernonoperatingincomesexpenses": 953000,
    "lossespartiallyrecoveredfromcyberinsurance": 1000000,
    "interestincomeondeposits": 1323000,
    "interestandinvestmentincomefrominvestmentsatfairvaluethroughothercomprehensiveincome": 9392000,
    "interestexpenseonleaseliabilities": 144000,
    "applicabletaxrate": 0.3,
    "corporateincometaxrate": 0.21,
    "averageeffectivetaxrate": 0.0884,
    "taxexpenseincomeatapplicabletaxrate": -198755000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 2203000000,
    "unusedtaxcreditsforwhichnodeferredtaxassetrecognised": 36500000,
    "profitlossfromcontinuingoperationsbeforetax": -263291000,
    "profitlossfromoverseasentities": -531727000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 17849000,
    "incometaxsuperdeductionofresearchanddevelopmentexpenses": 42980000,
    "taxlossesanddeductibletemporarydifferencesforwhichnodeferredincometaxassetsrecognized": 172349000,
    "taxeffectofforeigntaxrates": 53574000,
    "percentageoftaxdeductibleresearchanddevelopmentexpense": 1.75,
    "weightedaverageshares": 55044000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -2000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 2172000,
    "disposalspropertyplantandequipment": 3000,
    "depreciationpropertyplantandequipment": 3315000,
    "increasedecreasethroughtransfersfromconstructioninprogresspropertyplantandequipment": 301000,
    "noncurrentvalueaddedtaxreceivables": 1109000,
    "prepaymentsforpurchaseofnoncurrentassets": 408000,
    "othernoncurrentassetsother": 237000,
    "noncurrentvalueaddedtaxreceivablesrefund": 18000000,
    "additionstorightofuseassets": 3582000,
    "depreciationrightofuseassets": 446000,
    "rightofuseassetsexchangedifference": 1000,
    "rightofuseassetsrevaluedassetsatcost": 22284000,
    "rightofuseassetsaccumulateddepreciation": 742000,
    "cashoutflowforleases": 1500000,
    "researchdevelopmentandadministrationfacilityleaseexpirationperiod": "2023-04-30",
    "executiveandadminisitrationofficeleaseexpirationperiod": "2025-04",
    "interestexpense": 144000,
    "prepayments": 18871000,
    "currentprepaidexpenses": 2571000,
    "deposit": 356000,
    "otherreceivables": 1615000,
    "noncurrentfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincome": 11739000,
    "currentfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincome": 271499000,
    "interestincomerecognizedinprofitandlossrelatedtodebtinvestments": 9392000,
    "lossesrecognixedinothercomprehensiveincomerelatedtodebtinvestments": -2513000,
    "maturitiesofdebtinvestmentsatfairvaluethroughothercomprehensiveincome": 195400000,
    "financialassetsliabilitiesatfairvaluethroughprofitorloss": 127900000,
    "purchasesoffinancialassetsatfairvaluethroughothercomprehensiveincome": 737494000,
    "settlementsfairvaluemeasurementassets": 195364000,
    "accruedinterestsoffinancialassetatfairvaluethroughothercomprehensiveincome": 3333000,
    "discountaccretedoffinancialassetsatfairvaluethroughothercomprehensiveincome": 6059000,
    "gainslossesrecognisedinothercomprehensiveincomefairvaluemeasurementassets": -2513000,
    "exchangedifferenceoffinancialassetsatfairvaluethroughothercomprehensiveincome": 27985000,
    "financialassetsmeasuredatfairvaluethroughothercomprehensiveincome": 576994000,
    "purchasesfairvaluemeasurementassets": 41000000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementassets": 140000,
    "gainslossesrecognisedinprofitorlossonexchangedifferencesfairvaluemeasurementassets": 7267000,
    "issuedcapitalordinaryshares": 76560000,
    "numberofsharesoutstanding": 57448338,
    "increasedecreaseinnumberofordinarysharesissued": 132,
    "saleorissueoftreasuryshares": 132000,
    "issuanceoftreasuryshares": 25468,
    "sharessurrenderedandcancellationofshares": -60540,
    "numberofsharesissued": 3109000,
    "descriptionofshareholdervotingrights": "Pursuant to the Company’s shareholder agreement in effect as of the completion of the Series C financing (see Note 22), each of the Company’s founders was entitled to two or more votes to ensure the Co-Founders control the majority of the votes under certain circumstances.",
    "numberoftreasuryshares": 2407091,
    "percentageofentityprofittooffsetpriorlosses": 0.1,
    "percentageofentitysreserveregisteredcapital": 0.5,
    "statutoryreserve": 221500000,
    "ordinarysharesreserved": 5348217,
    "periodofgrantofsharebasedpaymentarrangement": "P10Y",
    "descriptionofvestingrequirementsforsharebasedpaymentarrangement": "Options granted under the plan are valid and effective for 10 years from the date of grant and vest over a service period which is generally four years; 25% of the granted options vest on the first anniversary of the grant date and the remaining options vest in equal monthly installments over next 36 months. ",
    "sharebasedpaymentawardvestingperiod": "P4Y",
    "sharebasedpaymentawardvestingrightspercentage": 0.25,
    "sharebasedpaymentequalmonthlyinstallments": "P36M",
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 6000000,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 2986547,
    "percentageofsharesequaltolesserofaggregatenumberofordinaryshares": 0.05,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P8Y8M12D",
    "currentretentionpayables": 200000,
    "numberofsharesissuedatconsolidation": 46232,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 20226000,
    "weightedaveragesharepriceshareoptionsgranted2019": 0.75,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.019,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.614,
    "increaseinpercentageofsharesequaltolesserofaggregatenumberofordinaryshares": 0.05,
    "sharebasedcompensationarrangementissuableupontheexerciseofincentiveshareoptions": 60000000,
    "purchaseofemployeesshares": 25468,
    "sharespurchasedatdiscountedprice": 0.74,
    "numberofoutstandingshareoptions": 5103627,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 1631309,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 1329119,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 3.4,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 9.6,
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 3.44,
    "descriptionofoptionlifeshareoptionsgranted": 10,
    "expectedearlyexercisemultiple": 2.2,
    "forfeiturerateshareoptionsgranted": 0.03,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 1.98,
    "constructionpayables": 1424000,
    "payrollwelfareandbonuspayables": 14959000,
    "accruedprofessionalservicefee": 5696000,
    "preferredsharessubscriptiondate": "2016-03-03",
    "preferredsharessubscriptiondateone": "2020-08-21",
    "preferredsharessubscriptiondatetwo": "2020-12-01",
    "preferredsharessubscriptionconsideration": 33110000,
    "conversionfrompreferredsharestoordinarysharesaftershareconsolidation": 24745572,
    "initialpublicofferingprice": 17,
    "adjustmentsforinvestmentandinterestincomefrominvestmentsatfairvaluethroughprofitandlossandwealthmanagementproducts": 140000,
    "adjustmentsforinvestmentincomefromwealthmanagementproducts": 9392000,
    "adjustmentsforamortisationexpense": 60000,
    "adjustmentsfordepreciationofpropertyplantandequipment": 4861000,
    "adjustmentsfordepreciationofrightsofuseassets": 2019000,
    "adjustmentsforsharebasedpayments": 45598000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -9629000,
    "gainslossesondisposalsofpropertyplantandequipment": -4000,
    "adjustmentsfordecreaseincreaseinotheroperatingreceivables": 23084000,
    "adjustmentsfordecreaseincreaseinotherassets": 17052000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 6315000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 2572000,
    "interestreceived": 2894000,
    "incometaxespaidrefund": 3221000,
    "constructionpayablesnoncashinvestingandfinancingactivities": 1424000,
    "noncashinvestingandfinancingactivities": 1424000,
    "liabilitiesarisingfromfinancingactivities": 2998000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -1515000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 3576000,
    "increasedecreasethroughinterestexpenseliabilitiesarisingfromfinancingactivities": 144000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 18254000,
    "keymanagementpersonnelcompensationsharebasedpayment": 18293000,
    "keymanagementpersonnelcompensationotherlongtermbenefits": 487000,
    "keymanagementpersonnelcompensation": 37034000,
    "percentageofannualrequirenetaftertaxprofits": 0.1,
    "percentageofreservefundofregisteredcapital": 0.5,
    "interestinsubsidiary": 2004960000,
    "othercurrentreceivables": 90197000,
    "othercurrentassets": 2571000,
    "equityattributabletoownersofparent": -2957777000
  },
  {
    "date": "2021-12-31",
    "symbol": "CNTB",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Connect Biopharma Holdings Limited",
    "entitycentralindexkey": 1835268,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entitywellknownseasonedissuer": "No",
    "icfrauditorattestationflag": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycommonstocksharesoutstanding": 55076319,
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "tradingsymbol": "CNTB",
    "security12btitle": "American Depositary Shares, each representing one Ordinary Share, par value $0.000174 per Share",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "E9",
    "entityfilenumber": "001-40212",
    "contactpersonnelname": "Dr. Zheng Wei",
    "entityaddressaddressline1": "Science and Technology Park, East R&D Building, 3rd Floor",
    "entityaddressaddressline2": "6 Beijing West Road",
    "entityaddresscityortown": "Taicang, Jiangsu",
    "entityaddresscountry": "CN",
    "entityaddresspostalzipcode": 215400,
    "cityareacode": 86,
    "localphonenumber": "512 5357 7866",
    "phonefaxnumberdescription": "+86 (21) 57940050",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorname": "PricewaterhouseCoopers Zhong Tian LLP",
    "auditorlocation": "Beijing, the People’s Republic of China",
    "auditorfirmid": 1424,
    "researchanddevelopmentexpense": 518021000,
    "administrativeexpense": 122445000,
    "otherincome": 18996000,
    "othergainslosses": -9966000,
    "profitlossfromoperatingactivities": -631436000,
    "financeincome": 622000,
    "financecosts": 44000,
    "financeincomecost": 578000,
    "gainslossesonfinancialliabilitiesatfairvaluethroughprofitorloss": -674269000,
    "profitlossbeforetax": -1305127000,
    "incometaxexpensecontinuingoperations": 1697000,
    "profitloss": -1306824000,
    "profitlossattributabletoownersofparent": -1306824000,
    "basicanddilutedearningslosspershare": -25,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 20426000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslationotherthantranslationofforeignoperations": -57464000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": -37038000,
    "comprehensiveincome": -1343862000,
    "comprehensiveincomeattributabletoownersofparent": -1343862000,
    "propertyplantandequipment": 59337000,
    "rightofuseassets": 22821000,
    "othernoncurrentassets": 18806000,
    "intangibleassetsandgoodwill": 560000,
    "noncurrentassets": 101524000,
    "otherreceivablesandprepayments": 47255000,
    "cashandcashequivalents": 1706880000,
    "currentassets": 1754135000,
    "assets": 1855659000,
    "noncurrentleaseliabilities": 163000,
    "noncurrentdeferredrevenue": 5000000,
    "noncurrentliabilities": 5163000,
    "tradeandotherpayablestotradesuppliers": 81195000,
    "otherpayablesandaccruals": 32840000,
    "currentleaseliabilities": 630000,
    "currentliabilities": 114665000,
    "liabilities": 119828000,
    "netassetsliabilities": 1735831000,
    "issuedcapital": 66000,
    "sharepremium": 4094434000,
    "treasuryshares": 1164000,
    "sharebasedcompensationreserves": 61904000,
    "otherreserves": -41244000,
    "retainedearnings": -2378165000,
    "equity": 1735831000,
    "equityandliabilities": 1855659000,
    "gainslossesonexchangedifferencesontranslationnetoftax": -37038000,
    "increasedecreaseinvalueofordinarysharesissued": 14000,
    "increasedecreasethroughconversionofconvertibleinstruments": 28000,
    "repurchaseofordinaryshares": 20765,
    "repurchaseofordinarysharesvalue": -1161000,
    "increasedecreasethroughexerciseofoptions": 2149000,
    "increasedecreaseinvalueofordinarysharesissuedtocofounders": 1417000,
    "increasedecreasethroughsharebasedpaymenttransactions": 57863000,
    "contributionsbyanddistributionstoownersofparent": 42000,
    "cashflowsfromusedinoperations": -544926000,
    "cashflowsfromusedinoperatingactivities": -544926000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 24941000,
    "purchaseofavailableforsalefinancialassets": 114500000,
    "proceedsfromdisposalormaturityofavailableforsalefinancialassets": 128004000,
    "paymentforrightofuseassets": 22284000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 304000,
    "cashflowsfromusedininvestingactivities": -34025000,
    "proceedsfromexerciseofoptions": 243000,
    "proceedsfromissueofordinaryshares": 1431775000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 805000,
    "paymentstoacquireorredeementitysshares": 3674000,
    "paymentinrelationtolistingexpenses": 111440000,
    "cashflowsfromusedinfinancingactivities": 1316099000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 737148000,
    "effectofexchangeratechangesoncashandcashequivalents": -40344000,
    "entityincorporationdateofincorporation": "2015-11-23",
    "countryofincorporation": "Cayman Islands",
    "addressofregisteredofficeofentity": "P.O. Box 613, Harbour Centre, George Town, Grand Cayman KY1-1107, Cayman Islands.",
    "numberofsharesrepresentedbyonedepositaryshares": 1,
    "parvaluepershare": 0.000174,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Investment holding",
    "principalplaceofbusinessofsubsidiary": "Hong Kong",
    "proportionofownershipinterestinsubsidiary": 1,
    "accumulatedothercomprehensiveincome": -2378200000,
    "cash": 440100000,
    "closingforeignexchangerate": 6.3757,
    "depreciationmethodpropertyplantandequipment": "Depreciation is calculated using the straight-line method",
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P10Y",
    "operatingleasetermofcontract": "P2Y",
    "numberofsegments": 1,
    "preferredsharesconversionratio": 1,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P5Y",
    "descriptionofusefullifepropertyplantandequipment": "Shorter of lease term",
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -3309000,
    "percentageofforeignexchangetransaction": 0.05,
    "increasedecreaseinforeignexchangetransactions": 7500000,
    "otherpayables": 21456000,
    "leaseliabilities": 653000,
    "financialliabilities": 103304000,
    "financialassets": 6423000,
    "purchasesfairvaluemeasurementassets": 114500000,
    "settlementsfairvaluemeasurementassets": 128004000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementassets": 436000,
    "clinicaltrialsrelatedexpenses": 424724000,
    "employeebenefitsexpense": 120173000,
    "professionalfeesexpense": 69498000,
    "rawmaterialsandconsumablesused": 13718000,
    "depreciationandamortisationexpense": 4082000,
    "officeexpenses": 3653000,
    "otherexpensebynature": 4618000,
    "expensebynature": 640466000,
    "expensefromsharebasedpaymenttransactionswithemployees": 57863000,
    "wagesandsalaries": 56122000,
    "welfareexpenses": 4820000,
    "housingfunds": 1368000,
    "governmentgrants": 18996000,
    "revenuefromgovernmentgrants": 11000000,
    "revenuefromgovernmentgrantsfromothersubsidies": 6200000,
    "revenuefromgovernmentasanincentiveforresearchanddevelopment": 1600000,
    "investmentincome": 436000,
    "othernonoperatingincomesexpenses": -7093000,
    "lossespartiallyrecoveredfromcyberinsurance": 1000000,
    "interestincomeondeposits": 622000,
    "interestexpenseonleaseliabilities": 44000,
    "applicabletaxrate": 0.3,
    "averageeffectivetaxrate": 0.0884,
    "taxexpenseincomeatapplicabletaxrate": -326282000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 1327000000,
    "unusedtaxcreditsforwhichnodeferredtaxassetrecognised": 13740000,
    "profitlossfromcontinuingoperationsbeforetax": -233382000,
    "profitlossfromoverseasentities": -1071745000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 13663000,
    "incometaxsuperdeductionofresearchanddevelopmentexpenses": 35523000,
    "taxlossesanddeductibletemporarydifferencesforwhichnodeferredincometaxassetsrecognized": 114121000,
    "taxeffectofforeigntaxrates": -235718000,
    "percentageoftaxdeductibleresearchanddevelopmentexpense": 1.75,
    "weightedaverageshares": 52177000,
    "basicearningslosspershare": -25,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 30440000,
    "disposalspropertyplantandequipment": 234000,
    "depreciationpropertyplantandequipment": 2142000,
    "increasedecreasethroughtransfersfromconstructioninprogresspropertyplantandequipment": 2449000,
    "noncurrentvalueaddedtaxreceivables": 18045000,
    "prepaymentsforpurchaseofnoncurrentassets": 341000,
    "othernoncurrentassetsother": 420000,
    "additionstorightofuseassets": 22284000,
    "depreciationrightofuseassets": 297000,
    "rightofuseassetsrevaluedassetsatcost": 22284000,
    "rightofuseassetsaccumulateddepreciation": 297000,
    "cashoutflowforleases": 800000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 12000,
    "expenserelatingtoleasesoflowvalueassetsforwhichrecognitionexemptionhasbeenused": 58000,
    "interestexpense": 114000,
    "prepayments": 36879000,
    "deposit": 4312000,
    "currentprepaidexpenses": 3953000,
    "otherreceivables": 2111000,
    "effectiveinterestrateoffinancialassetsreclassifiedoutoffinancialassetsatfairvaluethroughprofitorloss": 0.0148,
    "issuedcapitalordinaryshares": 76560000,
    "numberofsharesoutstanding": 57483410,
    "increasedecreaseinnumberofordinarysharesissued": 12937500,
    "conversionfrompreferredsharestoordinaryshares": 24791804,
    "increasedecreaseinnumberofordinarysharesissuedtocofounders": 121080,
    "descriptionofshareholdervotingrights": "Pursuant to the Company’s shareholder agreement in effect as of the completion of the Series C financing (see Note 22), each of the Company’s founders is entitled to two or more votes to ensure the Co-Founders control the majority of the votes under certain circumstances.",
    "numberoftreasuryshares": 2407091,
    "percentageofentityprofittooffsetpriorlosses": 0.1,
    "percentageofentitysreserveregisteredcapital": 0.5,
    "statutoryreserve": 288900000,
    "sharesreservedforfutureissuanceundertwothousandnineteenstockincentiveplan": 2407091,
    "periodofgrantofsharebasedpaymentarrangement": "P10Y",
    "descriptionofvestingrequirementsforsharebasedpaymentarrangement": "Options granted under the plan are valid and effective for 10 years from the date of grant and vest over a service period which is generally four years; 25% of the granted options vest on the first anniversary of the grant date and the remaining options vest in equal monthly installments over next 36 months. ",
    "sharebasedpaymentawardvestingperiod": "P4Y",
    "sharebasedpaymentawardvestingrightspercentage": 0.25,
    "sharebasedpaymentequalmonthlyinstallments": "P36M",
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 600000,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 2403660,
    "percentageofsharesequaltolesserofaggregatenumberofordinaryshares": 0.01,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P9Y2M12D",
    "numberofsharesissued": 342144,
    "numberofsharesissuedatconsolidation": 121080,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 26532000,
    "weightedaveragesharepriceshareoptionsgranted2019": 4.3,
    "weightedaveragesharepriceshareoptionsgrantedatconsolidation": 1.57,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.012,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.605,
    "numberofoutstandingshareoptions": 3748389,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 163773,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 157381,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 485324,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 13.8,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.9,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 14.7,
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 13.8,
    "descriptionofoptionlifeshareoptionsgranted": 10,
    "expectedearlyexercisemultiple": 2.2,
    "forfeiturerateshareoptionsgranted": 0.03,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 10.6,
    "constructionpayables": 16576000,
    "payrollwelfareandbonuspayables": 11384000,
    "accruedprofessionalservicefee": 2318000,
    "preferredsharessubscriptiondate": "2016-03-03",
    "preferredsharessubscriptiondateone": "2020-08-21",
    "preferredsharessubscriptiondatetwo": "2020-12-01",
    "preferredsharessubscriptionconsideration": 33110000,
    "conversionfrompreferredsharestoordinarysharesaftershareconsolidation": 24745572,
    "percentageofvotingequityinterestsacquired": 0.5,
    "internalrateofreturn": 0.08,
    "redemptionpricepercentage": 1.5,
    "initialpublicofferingprice": 17,
    "increasedecreasethroughamountsrecognisedinprofitorlossaggregatedifferencebetweenfairvalueatinitialrecognitionandamountdeterminedusingvaluationtechniqueyettoberecognised": 674269000,
    "gainslossesonconversiontoordinarysharesuponinitialpublicoffering": 2743625000,
    "adjustmentsforinvestmentincomefromwealthmanagementproducts": 436000,
    "adjustmentsforamortisationexpense": 43000,
    "adjustmentsfordepreciationofpropertyplantandequipment": 3130000,
    "adjustmentsfordepreciationofrightsofuseassets": 909000,
    "adjustmentsforsharebasedpayments": 57863000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 3309000,
    "adjustmentsforfairvaluegainslosses": 674269000,
    "gainslossesondisposalsofpropertyplantandequipment": -250000,
    "adjustmentsfordecreaseincreaseinotheroperatingreceivables": -16116000,
    "adjustmentsfordecreaseincreaseinotherassets": -8206000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": -11459000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 56601000,
    "constructionpayablesnoncashinvestingandfinancingactivities": 16576000,
    "fairvaluechangesoffinancialinstrumentswithpreferredrights": 674269000,
    "noncashinvestingandfinancingactivities": 690845000,
    "liabilitiesarisingfromfinancingactivities": 793000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -805000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 641000,
    "increasedecreasethroughinterestexpenseliabilitiesarisingfromfinancingactivities": 44000,
    "increasedecreasethrougheffectofchangesinforeignexchangeratesliabilitiesarisingfromfinancingactivities": -2152000,
    "increasedecreasethroughchangesinfairvaluesliabilitiesarisingfromfinancingactivities": 674269000,
    "increasedecreasethroughconversiontoordinarysharesliabilitiesarisingfromfinancingactivities": -2743625000,
    "capitalcommitments": 146878000,
    "contractualcapitalcommitments": 146900000,
    "squarefeetofoperatingleasearea": 3600,
    "operatingleasecosts": 600000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 18100000,
    "keymanagementpersonnelcompensationsharebasedpayment": 28266000,
    "keymanagementpersonnelcompensationotherlongtermbenefits": 308000,
    "keymanagementpersonnelcompensation": 46674000,
    "percentageofannualrequirenetaftertaxprofits": 0.1,
    "percentageofreservefundofregisteredcapital": 0.5,
    "interestinsubsidiary": 1177380000,
    "othercurrentreceivables": 86352000,
    "equityattributabletoownersofparent": 2694130000
  }
]